AsurDx Equine Infectious Anemia (EIA) Antibody Test

The AsurDxTM Equine Infectious Anemia (EIA) Antibody Test Kit is designed for the detection of antibodies specific to Equine Infectious Anemia (EIA) in horse serum and plasma.

Feature


  • Detects EIA antibodies of the IgG in horse serum/plasma;
  • Procedures last less than 30 minutes;
  • Provides a simple, rapid, sensitive and cost-effective enzyme-based immunoassay (ELISA) screening method

*Availability/Distribution: Product is designed and developed by BioStone US Texas headquarter and manufactured/assembled by BioStone oversea subsidiaries or partners. Currently, the product is only available outside of the USA. Regulatory requirements vary by oversea countries; the product may not be available in your geographic area.

Specification


MethodColorimetric ELISA
Coated AntigenEIA
Incubation Time30 minutes
StorageAt least 12 months
SpecificityEIA serogroup-specific antibodies in horse serum/plasma

Order Information


Catalog Number10059-0210059-05
Plates2 plates5 plates
Reactions192480
Plate Format12 X 8-well strips12 X 8-well strips

About Disease


EIA is a potentially fatal blood-borne infectious viral disease that produces a persistent infection among equids nearly worldwide. It is caused by an RNA virus classified in the Lentivirus genus, family Retroviridae. EIA can present as an acute, subacute, or chronic infection. On occasion, the EIA virus can be a cause of significant morbidity and mortality. The most frequently encountered form of the disease is the inapparent, chronically infected carrier. There is no vaccine or treatment for the disease, and it is often difficult to differentiate EIA from other fever-producing diseases, including anthrax, influenza, and equine encephalitis. EIA was difficult to diagnose and identify until 1970, when the agar-gel immunodiffusion test was developed. More recently, enzyme-linked immunosorbent assays (ELISA tests) reduced the time for a lab result from at least 24 hours to 1-2 hours. Accurate tests allow us to identify and remove positive reactors from herds and effectively block the spread of EIA among tested populations.